Tramadol vs placebo
Serious adverse events · adults with neuropathic pain
1 finding from 1 review
- no estimate extractedStudies not reportedVery low
Findings
What do systematic reviews say?
461 questions · 472 findings · 42 reviews · Neuromuscular
No studies found 93 · 19.7%GRADE not reported 81 · 17.2%Very low 99 · 21%Low 103 · 21.8%Moderate 75 · 15.9%High 21 · 4.4%
Tramadol vs placebo
Death · adults with neuropathic pain
1 finding from 1 review
- no estimate extractedStudies not reportedVery low
Oxcarbazepine vs placebo
At least 50% reduction in pain · painful diabetic neuropathy
It is very uncertain whether oxcarbazepine changes reduction in participant‐reported pain scores by at least 50% from… compared with placebo (very low certainty).
1 finding from 1 review
- RR 1.91 [1.08, 3.39]1 study · 146 participantsVery low
Oxcarbazepine vs placebo
At least 30% reduction in pain · painful diabetic neuropathy
It is very uncertain whether oxcarbazepine changes reduction in participant‐reported pain scores by at least 30% from… compared with placebo (very low certainty).
1 finding from 1 review
- RR 1.57 [1.01, 2.44]1 study · 146 participantsVery low
Oxcarbazepine vs placebo
Participants' global impression of their change in pain Participant's global assessment of therapeutic effect, 'much' or 'very much' · painful diabetic neuropathy
It is very uncertain whether oxcarbazepine changes participants' global impression of their change in pain… compared with placebo (very low certainty).
1 finding from 1 review
- RR 1.46 [1.13, 1.88]2 studies · 493 participantsVery low
Oxcarbazepine vs placebo
Serious adverse effects · painful diabetic neuropathy
Oxcarbazepine probably leads to higher serious adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
- RR 3.65 [1.45, 9.2]3 studies · 634 participantsModerate
Low‐level laser therapy vs placebo
Overall improvement in CTS: SSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome
1 finding from 1 review
- no estimate extracted7 studies · 327 participantsVery low
Low‐level laser therapy vs placebo
Overall improvement in CTS: SSS: long term Scale from: 1 to 5 · carpal tunnel syndrome
1 finding from 1 review
- no estimate extracted1 study · 25 participantsVery low
Low‐level laser therapy and a splint vs placebo and a splint
Overall improvement in CTS: SSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome
1 finding from 1 review
- no estimate extracted1 study · 112 participantsVery low
Low‐level laser therapy and a splint vs placebo and a splint
Overall improvement in CTS: SSS: long term ‐ not measured · carpal tunnel syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐level laser therapy and a splint vs placebo and a splint
Overall improvement in CTS: FSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome
1 finding from 1 review
- no estimate extracted1 study · 112 participantsVery low
Low‐level laser therapy and a splint vs placebo and a splint
Overall improvement in CTS: FSS: long term ‐ not reported · carpal tunnel syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐level laser therapy and a splint vs placebo and a splint
Adverse events · carpal tunnel syndrome
It is very uncertain whether low‐level laser therapy and a splint changes adverse events compared with placebo and a splint (very low certainty).
1 finding from 1 review
- RR 2 [0.38, 10.48]1 study · 112 participantsVery low
Low‐level laser therapy, wrist splint, and vitamin B6 vs placebo, wrist splint, and vitamin B6
Overall improvement in CTS: SSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome
1 finding from 1 review
- no estimate extracted1 study · 33 participantsVery low
Low‐level laser therapy, wrist splint, and vitamin B6 vs placebo, wrist splint, and vitamin B6
Overall improvement in CTS: SSS: long term ‐ not measured · carpal tunnel syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐level laser therapy, wrist splint, and vitamin B6 vs placebo, wrist splint, and vitamin B6
Overall improvement in CTS: FSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome
1 finding from 1 review
- no estimate extracted1 study · 33 participantsVery low
Low‐level laser therapy, wrist splint, and vitamin B6 vs placebo, wrist splint, and vitamin B6
Overall improvement in CTS: FSS: long term ‐ not reported · carpal tunnel syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐level laser therapy vs placebo
Overall improvement in CTS: FSS: short term (< 3 months) Scale from: 1 to 5 · carpal tunnel syndrome
1 finding from 1 review
- no estimate extracted5 studies · 159 participantsVery low
Low‐level laser therapy, wrist splint, and vitamin B6 vs placebo, wrist splint, and vitamin B6
Adverse events · carpal tunnel syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Low‐level laser therapy vs placebo
Overall improvement in CTS: FSS: long term Scale from: 1 to 5 · carpal tunnel syndrome
1 finding from 1 review
- no estimate extracted1 study · 25 participantsVery low